Bought some more MVP this week. One of the first stocks I bought when i started trading. Has always been relatively overpriced on traditional metrics but has great promise.Been a wild ride over the years with that promise blunted by slow European roll out and FDA hurdles in America.Covid hasnt helped either. Late last year management changes saw a couple of CSL guys take over the helm. Alround that time they also bought back the European (exUK) distribution rights. I think it is about time for them to start showing some results
Also think it has started another move to the upside from the chart. There was also a biggish cross trade recently.
